MEDINDIA
English
हिन्दी
Español
français
中文
(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )
During the presentation, Dr. Deborah Dunsire, president and chiefexecutive officer, and Marsha Fanucci, chief financial officer and senior vicepresident, corporate strategy, will discuss the Company's 2007 financialresults as well as goals and financial guidance for 2008. The presentationwill be delivered at 8:00 a.m. ET on Thursday, February 7, 2008 from The GrandHyatt Hotel in New York, NY. The presentation will be archived for 30 days.
Before the presentation on February 7, 2008, the Company's 2007 year-endfinancial results will be issued in a press release.
About Millennium
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical companybased in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, anovel cancer product, and has a robust clinical development pipeline ofproduct candidates. The Company's research, development and commercializationactivities are focused in two therapeutic areas: oncology and inflammation.By applying its knowledge of the human genome, understanding of diseasemechanisms and industrialized drug discovery platform, Millennium isdeveloping an exciting pipeline of innovative product candidates. TheCompany's website is www.millennium.com.
Editors' Note: This press release is also available under the Mediasection of the Company's website at: www.millennium.com.
Contact:
Kyle Kuvalanka
(617) 761-4734
SOURCE Millennium Pharmaceuticals, Inc.
